Cancer and COVID-19 vaccines: a complex global picture

COVID-19 and Cancer Global Taskforce

doi:10.1016/S1470-2045(21)00244-8

Cancer and COVID-19 vaccines: a complex global picture

COVID-19 and Cancer Global Taskforce

Research output: Contribution to journal › Comment/debate › peer-review

19 Citations (Scopus)

Original language	English
Pages (from-to)	749-751
Number of pages	3
Journal	The Lancet Oncology
Volume	22
Issue number	6
DOIs	https://doi.org/10.1016/S1470-2045(21)00244-8
Publication status	Published - Jun 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1470-2045(21)00244-8

Cite this

@article{bc7b0d3c58cb489883d0d0579336ea92,

title = "Cancer and COVID-19 vaccines: a complex global picture",

author = "{COVID-19 and Cancer Global Taskforce} and Aasim Yusuf and Diana Sarfati and Booth, {Christopher M.} and Pramesh, {C. S.} and Dorothy Lombe and Ajay Aggarwal and Nirmala Bhoo-Pathy and Audrey Tsunoda and Verna Vanderpuye and Tezer Kutluk and Alice Sullivan and Deborah Mukherji and Miriam Mutebi and {van Hemelrijck}, Mieke and Richard Sullivan",

note = "Funding Information: We thank Sheeba Irshad and her team at Guy's and St Thomas' Hospital (London, UK) for their help in adapting the protocol in the appendix . NB-P reports unrestricted institutional educational and meeting grants from Pharmaceutical Association of Malaysia, Pfizer, Roche, Novartis, and AIA Berhad; personal speaker fees from Pfizer, Rocher and Novartis; and regional breast cancer board membership for Pfizer. All other authors declare no competing interests. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2021",

month = jun,

doi = "10.1016/S1470-2045(21)00244-8",

language = "English",

volume = "22",

pages = "749--751",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "6",

}

TY - JOUR

T1 - Cancer and COVID-19 vaccines

T2 - a complex global picture

AU - COVID-19 and Cancer Global Taskforce

AU - Yusuf, Aasim

AU - Sarfati, Diana

AU - Booth, Christopher M.

AU - Pramesh, C. S.

AU - Lombe, Dorothy

AU - Aggarwal, Ajay

AU - Bhoo-Pathy, Nirmala

AU - Tsunoda, Audrey

AU - Vanderpuye, Verna

AU - Kutluk, Tezer

AU - Sullivan, Alice

AU - Mukherji, Deborah

AU - Mutebi, Miriam

AU - van Hemelrijck, Mieke

AU - Sullivan, Richard

N1 - Funding Information: We thank Sheeba Irshad and her team at Guy's and St Thomas' Hospital (London, UK) for their help in adapting the protocol in the appendix . NB-P reports unrestricted institutional educational and meeting grants from Pharmaceutical Association of Malaysia, Pfizer, Roche, Novartis, and AIA Berhad; personal speaker fees from Pfizer, Rocher and Novartis; and regional breast cancer board membership for Pfizer. All other authors declare no competing interests. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/6

Y1 - 2021/6

UR - http://www.scopus.com/inward/record.url?scp=85106154829&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(21)00244-8

DO - 10.1016/S1470-2045(21)00244-8

M3 - Comment/debate

C2 - 33930324

AN - SCOPUS:85106154829

SN - 1470-2045

VL - 22

SP - 749

EP - 751

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 6

ER -

Cancer and COVID-19 vaccines: a complex global picture

UN SDGs

Access to Document

Other files and links

Cite this